Journal of Peking University (Health Sciences) ›› 2025, Vol. 57 ›› Issue (1): 1-6. doi: 10.19723/j.issn.1671-167X.2025.01.001

    Next Articles

Research progress in diagnosis and treatment of salivary gland tumors

Guangyan YU*(), Xin PENG*(), Min GAO, Peng YE, Na GE, Mengqi JIA, Bingyu LI, Zunan TANG, Leihao HU, Wenbo ZHANG   

  1. Department of Oral & Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology, Beijing 100081, China
  • Received:2024-10-30 Online:2025-02-18 Published:2025-01-25
  • Contact: Guangyan YU, Xin PENG E-mail:gyyu@263.net;pxpengxin@263.net
  • Supported by:
    the National Natural Science Foundation of China(39270723);the National Natural Science Foundation of China(30572050);the National Natural Science Foundation of China(30640093);the National Natural Science Foundation of China(82270993)

RICH HTML

  

Abstract:

Salivary gland tumor is one of the most common tumors in oral and maxillofacial regions. The diagnosis and treatment of salivary gland tumors had been a clinical characteristic project in Peking University School and Hospital of Stomatology since long time ago. Here we introduced the research progress in diagnosis and treatment of salivary gland tumors during the past 10 years. Among 7 190 cases of salivary gland tumors treated in this institution, 4 654 cases (64.7%) were benign, and 2 536 (35.3%) were malignant, with benign ∶ malignant ratio of 1.84 ∶ 1. Parotid was the most common location, followed by minor salivary gland and submandibular gland, while sublingular gland tumor was seldom seen. The proportion of minor salivary gland tumor was relatively high. Among 1 874 cases with primary malignant tumors, the cases with T3 and stage Ⅲ accounted for only 9.6% and 10.3%, respectively, which indicated that there was shortcoming in the T classification and clinical stage formulated by Union for International Cancer Control (UICC), and further revision was required. The 5, 10, and 15 year survival rates of 1 637 cases with postoperative follow-up were 93.1%, 87.2% and 79.3%, respectively, which were much higher than those we reported 30 years ago. The improvement of treatment results was related to more widely used combined treatment with surgery and postoperative radiotherapy, and the increase in patients with early stage. Adenoid cystic carcinoma was the malignant tumor with high rate of distant metastasis. The 5 and 10 year survival rates of the patients with pulmonary metastasis were 76.2% and 51.8%, respectively, which indicated that the pulmonary metastatic carcinomas developed slowly. Recurrent rate of carcinoma ex pleomorphic adenoma was 46.7% after single treatment of sur-gery, while it decreased to 27.5% after combined theraphy with surgery and radiotherapy, indicating that postoperative radiotheraphy could reduce the recurrent rate effectively. The normal myoepithelial cells had the inhibiting role in the invasion and metastasis of carcinoma ex pleomorphic adenoma. The evaluation of integrity of myoepithelial cells surrounding the tumor mass is helpful to understand the invasiveness of the tumors. The new surgical modalities such as extracapsular resection and partial sialoadenectomy were used in treatment of benign tumors of parotid gland and submandibular gland with advantages of decreased tissue damage and preservation of glandular function. Application of digital surgical techniques such as mixed reality combined with surgical navigation and real-time three-dimensional holograms in the surgical treatment of parotid gland tumors showed the benifits of more safety and precision, and less tissue da-mage.

Key words: Salivary gland neoplasms, Diagnosis, Therapy, Incidence, Clinical pathology

CLC Number: 

  • R739.87
1 于世凤. 口腔组织病理学[M]. (6版) 北京: 人民卫生出版社, 2007.
2 俞光岩, 马大权. 北京大学口腔医院唾液腺肿瘤研究50年回顾[J]. 北京大学学报(医学版), 2015, 47 (1): 1- 7.
3 Gao M , Hao Y , Huang MX , et al. Salivary gland tumours in a northern Chinese population: A 50-year retrospective study of 7 190 cases[J]. Int J Oral Maxillofac Surg, 2017, 46 (3): 343- 349.
doi: 10.1016/j.ijom.2016.09.021
4 Seifert G , Mieblke A , Haubrich J . Diseases of salivary glands: Pathology-diagnosis-treatment-facial nerve surgery[M]. Stuttgart: Geory Thieme Verlag, 1986: 393.
5 Eveson JW , Cawson RA . Salivary gland tumors: A review of 2 410 cases with particular reference to histological types, site, age, and distribution[J]. J Pathol, 1985, 146 (1): 51- 58.
doi: 10.1002/path.1711460106
6 Sobin LH , Gospodarowicz MK , Wittekind CH . International Union Against Cancer (UICC) TNM classification of malignant tumours[M]. 7th ed Chichester: Wiley-Blackwell, 2010.
7 Jia MQ , Gao M , Ye P , et al. Survival outcome of salivary gland carcinoma: A 50-year retrospective study with long-term follow-up[J]. J Oral Maxillofac Surg, 2022, 80 (12): 2003- 2014.
doi: 10.1016/j.joms.2022.08.007
8 Yu GY , Ma DQ . Carcinoma of the salivary glands: A clinico-pathologic study of 405 cases[J]. Semin Surg Oncol, 1987, 3 (4): 240- 244.
doi: 10.1002/ssu.2980030405
9 Gao M , Hao Y , Huang MX , et al. Clinicopathologic study of distant metastases of salivary adenoid cystic carcinoma[J]. Int J Oral Maxillofac Surg, 2013, 42 (8): 923- 928.
doi: 10.1016/j.ijom.2013.04.006
10 Eneroth CM , Zetterberg A . Malignancy in pleomorphic adenoma. A clinical and microspectrophotometric study[J]. Acta Otolaryngol, 1974, 77 (6): 426- 432.
11 Ye P , Gao Y , Mao C , et al. Carcinoma ex pleomorphic adenoma: Is it a high-grade malignancy?[J]. J Oral Maxillofac Surg, 2016, 74 (10): 2093- 2104.
doi: 10.1016/j.joms.2016.03.037
12 Weissferdt A , Moran CA . Pulmonary salivary gland-type tumors with features of malignant mixed tumor (carcinoma ex pleomorphic adenoma): A clinicopathologic study of five cases[J]. Am J Clin Pathol, 2011, 136 (5): 793- 798.
doi: 10.1309/AJCP50FBZWSACKIP
13 Ye P , Gao Y , Wei T , et al. Absence of myoepithelial cells correlates with invasion and metastasis of carcinoma ex pleomorphic adenoma[J]. Int J Oral Maxillofac Surg, 2017, 46 (8): 958- 964.
doi: 10.1016/j.ijom.2017.03.031
14 李炳雨, 唐祖南, 胡耒豪, 等. 腮腺微小肿瘤的临床病理研究[J]. 北京大学学报(医学版), 2022, 54 (2): 335- 339.
15 Mao Y , Lee B , Sun Z , et al. The efficacy of clinicopatholo-gical and imaging features in differentiating benign from malignant parotid micro- and minitumors: A retrospective analysis[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2024, 138 (3): 440- 452.
doi: 10.1016/j.oooo.2024.04.014
16 高敏, 陈艳, 高岩, 等. 紧贴面神经的腮腺多形性腺瘤的临床病理特点及处理[J]. 北京大学学报(医学版), 2012, 44 (1): 43- 46.
17 Xu H , Mao C , Liu JM , et al. Microanatomic study of the vascular and duct system of the submandibular gland[J]. J Oral Maxillofac Surg, 2011, 69 (4): 1103- 1107.
doi: 10.1016/j.joms.2010.03.006
18 Ge N , Peng X , Zhang L , et al. Partial sialoadenectomy for treatment of benign tumors in the submandibular gland[J]. Int J Oral Maxillofac Surg, 2016, 45 (6): 750- 755.
doi: 10.1016/j.ijom.2015.12.013
19 Tang ZN , Hu LH , Yu Y , et al. Mixed reality combined with surgical navigation in resection of micro- and mini-tumors of the paro-tid gland: A pilot study[J]. Laryngoscope, 2024, 134 (4): 1670- 1678.
doi: 10.1002/lary.31104
20 Hu LH , Yu Y , Tang ZN , et al. Direct visualization of intraparotid facial nerve assisting in parotid tumor resection[J]. J Cranio-maxillofac Surg, 2024, 52 (5): 659- 665.
doi: 10.1016/j.jcms.2024.03.014
[1] Jiale GAO, Zhongtao ZHANG. Current status and future perspectives of precision treatment for locally advanced rectal cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 247-250.
[2] Hai WANG, Yizhou JIANG. Molecular mechanisms and clinical applications of anti-angiogenic therapy in precision treatment of breast cancer [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 251-256.
[3] Hao FU, Luyan SHEN, Bingyang HUANG, Shaohua MA. Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 266-271.
[4] Jialin LI, Liqiao CHEN, Jiatian TANG, Yan WU, Anqiang WANG. Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 399-404.
[5] Zichen PAN, Kai CHEN, Yukun HOU, Bohan YANG, Jixin ZHANG, Yongsu MA, Xiaodong TIAN, Yinmo YANG. Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 431-435.
[6] Ye ZHAO, Xiaoli DIAO, Yan XIONG. Application of cell transfer technology in pathological diagnosis of micro-volume cell fluid [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 208-213.
[7] Yue WANG, Yuhong LIANG. Florid cemento-osseous dysplasia: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 220-224.
[8] Yanting CHI, Hongjie JIANG, Yan CHEN, Zhixiu XU, Binbin LI. Value of direct immunofluorescence in the diagnosis of oral mucosal pemphigus vulgaris: A retrospective study based on multi-index combined analysis [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 68-73.
[9] Jingyan GU, Xinyi LI, Jinxia ZHAO, Rong MU. Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1193-1197.
[10] Xiaolin WANG, Luyao LI, Wen ZHANG, Hongyan WANG. Clinicopathological analysis of mesonephric-like adenocarcinoma in the corpusuteri: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1208-1212.
[11] Xiaodi XIAO, Youchen XIA, Jianying LIU, Peng FU. Left sided sternocleidomastoid interosseous intravascular papillary endothelial hyperplasia: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 1002-1004.
[12] Xiangyu SUN, Chao YUAN, Xinzhu ZHOU, Jing DIAO, Shuguo ZHENG. Application of salivary micro-ecosystem in early prevention and control of oral and systemic diseases [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 859-863.
[13] Zhemin LI, Jiafu JI, Guoxin LI, Ziyu LI, Zhaode BU, Xiangyu GAO, Di DONG, Lei TANG, Xiaofang XING, Shuqin JIA, Ting GUO, Lianhai ZHANG, Fei SHAN, Xin JI, Anqiang WANG. Development and dissemination of precision medicine approaches in gastric cancer management [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 864-867.
[14] Yuanjie NIU, Zhongcheng XIN, Guiting LIN, Pan DING, Jiancheng PAN, Yuhong FENG, Yinglu GUO. Low-level laser therapy for the treatment of male infertility and erectile dysfunction [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 627-632.
[15] Wanwei HUANG, Xianshen SHA, Yibao ZHANG, Guohao WU, Feng LUO, Zhihui CHEN, Dongming YE, Xuesong LI, Caiyong LAI. Total 3D laparoscopic ileal ureters replacement for bilateral ureters combined with bladder augmentation in the management of post-radiotherapy bilateral ureteral strictures and contracted bladder [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 789-795.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!